Kim Yun H, Bae Jin U, Lee Seung J, Park So Y, Kim Chi D
Department of Pharmacology, School of Medicine, Pusan National University, Yangsan, Gyeongnam 626-870, Republic of Korea.
Department of Pharmacology, School of Medicine, Pusan National University, Yangsan, Gyeongnam 626-870, Republic of Korea.
Vascul Pharmacol. 2015 Sep;72:35-42. doi: 10.1016/j.vph.2015.04.015. Epub 2015 May 9.
Silent mating type information regulation 2 homolog 1 (SIRT1) is known as a key regulator in the protection of various vascular disorders, however, no direct evidences have been reported in the progression of atherosclerosis. Considering the pivotal role of matrix metalloproteinase-2 (MMP-2) in plaque destabilization, this study investigated the role of SIRT1 on MMP-2 production in vascular smooth muscle cells (VSMCs) induced by platelet activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine). In VSMCs stimulated with resveratrol, SIRT1 activator, PAF receptor (PAFR) was internalized and then its protein levels were diminished. It was attenuated in cells pretreated with proteasome or lysosome inhibitor. Also, the degradation of PAFR in SIRT1-stimulated cells was significantly attenuated by β-arrestin2 depletion. In cells treated with nicotinamide, SIRT1 deacetylase inhibitor, PAFR internalization by resveratrol or reSIRT1 was inhibited, demonstrating that deacetylation of SIRT1 is an important step in SIRT1-induced PAFR down-regulation. Moreover, PAF-induced MMP-2 production in VSMCs and aorta was attenuated by resveratrol. In the aorta of SIRT1 transgenic mice, the PAF-induced MMP-2 expression was prominently attenuated compared to that in wild type mice. Taken together, it was suggested that SIRT1 down-regulated PAFR in VSMCs via β-arrestin2-mediated internalization and degradation, leading to an inhibition of PAF-induced MMP-2 production.
沉默交配型信息调节因子2同源物1(SIRT1)是保护各种血管疾病的关键调节因子,然而,在动脉粥样硬化进展方面尚无直接证据报道。考虑到基质金属蛋白酶-2(MMP-2)在斑块不稳定中的关键作用,本研究调查了SIRT1在血小板活化因子(PAF,1-O-烷基-2-乙酰基-sn-甘油-3-磷酸胆碱)诱导的血管平滑肌细胞(VSMC)中MMP-2产生的作用。在用白藜芦醇(SIRT1激活剂)刺激的VSMC中,PAF受体(PAFR)被内化,然后其蛋白水平降低。在用蛋白酶体或溶酶体抑制剂预处理的细胞中这种情况减弱。此外,β-抑制蛋白2缺失显著减弱了SIRT1刺激细胞中PAFR的降解。在用烟酰胺(SIRT1去乙酰化酶抑制剂)处理的细胞中,白藜芦醇或重组SIRT1诱导的PAFR内化受到抑制,表明SIRT1的去乙酰化是SIRT1诱导PAFR下调的重要步骤。此外,白藜芦醇减弱了VSMC和主动脉中PAF诱导的MMP-2产生。在SIRT1转基因小鼠的主动脉中,与野生型小鼠相比,PAF诱导的MMP-2表达显著减弱。综上所述,提示SIRT1通过β-抑制蛋白2介导的内化和降解下调VSMC中的PAFR,导致PAF诱导的MMP-2产生受到抑制。